Advertisement
Screener

Autolus Therapeutics plc (AUTL) Patents: Active

Autolus Therapeutics plc Active Patents

57 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2023-05-24: Application 18323090; Invention CELL; Applicant AUTOLUS LIMITED; Status Patented Case.
  • 2023-01-24: Application 18158754; Invention A CELL LEXPRESSING TWO CHIMERIC ANTIGEN RECEPTORS (CARS) AT THE CELL SURFACE; Applicant AUTOLUS LIMITED; Status Patented Case.
  • 2023-01-12: Application 18153990; Invention Chimeric Antigen Receptor (CAR) Comprising A CD19-Binding Domain; Applicant AUTOLUS LIMITED; Status Patented Case.
  • 2022-08-29: Application 17823003; Invention Engineered Cytolytic Immunecell; Applicant AUTOLUS LIMITED; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2023-05-2418323090CELLAUTOLUS LIMITEDPatented Case2025-01-0712187769US20240075066A1
Martin Pulé
Shaun Cordoba
Simon Thomas
Shimobi Onuoha
Matteo Righi
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
MONSHIPOURI, MARYAM
2023-01-2418158754A CELL LEXPRESSING TWO CHIMERIC ANTIGEN RECEPTORS (CARS) AT THE CELL SURFACEAUTOLUS LIMITEDPatented Case2025-08-2612398194US20230331810A1
Martin Pulé
Shaun Cordoba
Shimobi Onuoha
Simon Thomas
United Kingdom
United Kingdom
United Kingdom
United Kingdom
REDDIG, PETER J
2023-01-1218153990Chimeric Antigen Receptor (CAR) Comprising A CD19-Binding DomainAUTOLUS LIMITEDPatented Case2026-07-2812692313US20230220077A1
Martin Pulé
Leila Mekkaoui
Persis Amrolia
Sara Ghorashian
Anne Kramer
Gordon Cheung
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
BELYAVSKYI, MICHAIL A
2022-08-2917823003Engineered Cytolytic ImmunecellAUTOLUS LIMITEDPatented Case2025-12-0912492410US20230090553A1
Shaun Cordoba
Shimobi Onuoha
Alexander Kinna
Simon Thomas
Ram Jha
Martin Pulé
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
HOPKINS, SAMANTHA LAKE
2022-08-0317817271ANTI TRBC1 ANTIGEN BINDING DOMAINSAutolus LimitedPatented Case2026-01-0612516119US20230053849A1
Shaun Cordoba
Simon Thomas
Shimobi Onuoha
Ram Jha
Wen Chean Lim
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
EDGINGTONGIORDANO, FRANCESCA
2022-07-2617815110CHIMERIC TRANSMEMBRANE PROTEIN COMPRISING ANTIBODY DIMERIZATION DOMAINS AND A TYPE I CYTOKINE RECEPTOR ENDODOMAIN, ENCODING NUCLEIC ACIDS THEREOF AND METHODS OF USE THEREOFAUTOLUS LIMITEDPatented Case2025-02-2512234295US20230133682A1
Martin PULÉ
Shaun CORDOBA
Matteo RIGHI
James SILLIBOURNE
Shimobi ONUOHA
Simon THOMAS
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
LANDSMAN, ROBERT S
2022-06-1017784392Antigen-Binding DomainAUTOLUS LIMITEDPatented Case2025-12-1612496314US20240252534A1
Shimobi Onuoha
Mathieu Ferrari
Marco Della Peruta
Alexander Kinna
Shaun Cordoba
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
BERHANE, SELAM
2022-06-0317832371Method for Depleting Malignant T-CellsAUTOLUS LIMITEDPatented Case2024-01-3011885807US20230018688A1
Martin Pulé
Paul Maciocia
United Kingdom
United Kingdom
MONTANARI, DAVID A
2022-06-0317832341METHODSAUTOLUS LIMITEDPatented Case2024-05-1411982673US20230026111A1
Martin Pulé
Paul Maciocia
United Kingdom
United Kingdom
MONTANARI, DAVID A
2022-06-0317832225Method for Depleting Malignant T-CellsAUTOLUS LIMITEDPatented Case2024-01-3011885806US20230019650A1
Martin Pulé
Paul Maciocia
United Kingdom
United Kingdom
MONTANARI, DAVID A
2022-06-0317832162METHODSAUTOLUS LIMITEDPatented Case2024-05-1411982672US20230021548A1
Martin Pulé
Paul Maciocia
United Kingdom
United Kingdom
MONTANARI, DAVID A
2022-05-1717746664COMPOSITIONS AND METHODS COMPRISING ENGINEERED CHIMERIC ANTIGEN RECEPTOR AND MODULATOR OF CARAUTOLUS LIMITEDPatented Case2025-04-0812269860US20220364116A1
Martin Pulé
Vijay Peddareddigari
Christian Itin
United Kingdom
United Kingdom
United Kingdom
WESTON, ALYSSA G
2022-05-1717746642CYTOLYTIC IMMUNE CELL COMPRISING BCMA- AND CD19-SPECIFIC CHIMERIC ANTIGEN RECEPTORSAUTOLUS LIMITEDPatented Case2025-10-2812454578US20220356260A1
Martin Pulé
Shaun Cordoba
Simon Thomas
Shimobi Onuoha
Mathieu Ferrari
Wen Chean Lim
Biao Ma
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
CUNNINGCHEN, KATHLEEN MARY
2022-04-1817723209CHIMERIC ANTIGEN RECEPTORAUTOLUS LIMITEDPatented Case2023-02-2811590170US20220257659A1
Martin Pulé
Evangelia Kokalaki
Shaun Cordoba
Shimobi Onuoha
Simon Thomas
Biao Ma
Mathieu Ferrari
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
RAWLINGS, STEPHEN L
2022-01-1317626990VIRUS-LIKE PARTICLEAUTOLUS LIMITEDPatented Case2026-06-1612655388US20220249566A1
Abigail Culshaw
Rosie Woodruff
Alexander Burkard
Martin Madill
United Kingdom
United Kingdom
United Kingdom
United Kingdom
MIANO, JOSEPH PAUL
2021-12-2217560022CHIMERIC RECEPTOR COMPRISING A LIGAND BINDING DOMAIN AND AN ENDODOMAIN COMPRISING A CYTOKINE RECEPTOR ENDODOMAIN AND AN INTRACELLULAR T CELL SIGNALLING DOMAINAUTOLUS LIMITEDPatented Case2026-05-1212624088US20220275052A1
Martin Pulé
Shaun Cordoba
Matteo Righi
United Kingdom
United Kingdom
United Kingdom
HOWARD, ZACHARY C
2021-11-1217525244CELLAutolus LimitedPatented Case2026-04-2812612443US20220267404A1
Martin Pulé
Shaun Cordoba
Simon Thomas
Khai Kong
United Kingdom
United Kingdom
United Kingdom
United Kingdom
LEE, YIE CHIA
2021-10-1217499687ANTI TRBC1 ANTIGEN BINDING DOMAINSAUTOLUS LIMITEDPatented Case2022-09-0611434293US20220098300A1
Shaun Cordoba
Simon Thomas
Shimobi Onuoha
Ram Jha
Wen Chean Lim
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
ROARK, JESSICA HOPE
2021-04-2917290188BINDING DOMAINAUTOLUS LIMITEDPatented Case2025-06-1012325733US20220041718A1
Anna Bulek
Martin Pulé
Shaun Cordoba
Simon Thomas
Shimobi Onuoha
Mathieu Ferrari
Vania Baldan
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
SKELDING, ZACHARY S
2021-04-2117287307T-CELL RECEPTOR CONSTANT REGION 1 ANTIBODY OR T-CELL RECEPTOR CONSTANT REGION 2 ANTIBODYAUTOLUS LIMITEDPatented Case2024-04-0211945867US20210355217A1
Martin Pulé
Shimobi Onuoha
Ana Margarida Neves
Mathieu Ferrari
Paul Maciocia
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
SKELDING, ZACHARY S
2021-03-0917196670CHIMERIC ANTIGEN RECEPTORAUTOLUS LIMITEDPatented Case2024-01-2311879016US20210403596A1
Martin Pulé
John Anderson
Simon Thomas
United Kingdom
United Kingdom
United Kingdom
BURKHART, MICHAEL D
2021-03-0417192561Retroviral and Lentiviral VectorsAUTOLUS LIMITEDPatented Case2023-11-1411814641US20210348191A1
Martin Pulé
Leila Mekkaoui
United Kingdom
United Kingdom
CHESTNUT, BARRY A
2021-01-2817264217MOLECULAR ASSESSMENT OF TRBC USAGEAUTOLUS LIMITEDPatented Case2025-03-0412241124US20220010377A1
Shimobi Onuoha
Meggan Czapiga
Biao Ma
United Kingdom
United Kingdom
United Kingdom
MYERS, CARLA J
2020-12-1817254001NUCLEIC ACID CONSTRUCTAUTOLUS LIMITEDPatented Case2024-04-1611959084US20220106602A1
Shaun Cordoba
James Sillibourne
Martin Pulé
United Kingdom
United Kingdom
United Kingdom
KELLY, ROBERT M
2020-11-1317055387A CD79-SPECIFIC CHIMERIC ANTIGEN RECEPTORAUTOLUS LIMITEDPatented Case2025-03-0412241068US20220273710A1
Martin Pulé
Shaun Cordoba
Simon Thomas
Shimobi Onuoha
Mathieu Ferrari
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
CHEONG, CHEOM-GIL
2020-11-1117054670CHIMERIC ANTIGEN RECEPTORAUTOLUS LIMITEDPatented Case2024-04-2311963981US20210113618A1
Martin Pulé
Evangelia Kokalaki
Shaun Cordoba
Shimobi Onuoha
Simon Thomas
Biao Ma
Mathieu Ferrari
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
ROARK, JESSICA HOPE
2020-08-2016999012METHODS FOR TREATING CANCER OR MODULATING T CELLS OR NK CELLS IN A SUBJECT WITH CANCER BY ADMINISTERING CELLS COMPRISING CHIMERIC CYTOKINE RECEPTORSAUTOLUS LIMITEDPatented Case2022-10-2511479614US20210040228A1
Martin Pulé
Shaun Cordoba
Matteo Righi
James Sillibourne
Shimobi Onuoha
Simon Thomas
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
LANDSMAN, ROBERT S
2020-08-2016998756METHODS FOR TREATING CANCER OR MODULATING T CELLS OR NK CELLS IN A SUBJECT BY ADMINISTERING CELLS COMPRISING CHIMERIC TRANSMEMBRANE PROTEINSAUTOLUS LIMITEDPatented Case2022-10-2511479613US20210040227A1
Martin Pulé
Shaun Cordoba
Matteo Righi
James Sillibourne
Shimobi Onuoha
Simon Thomas
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
LANDSMAN, ROBERT S
2020-06-1216772260Cell Comprising a Chimeric Antigen Receptor or a Transgenic T-Cell Receptor and Comprising a Chimeric TNF ReceptorAUTOLUS LIMITEDPatented Case2025-05-2012304942US20210095003A1
Martin Pulé
Marco Della Peruta
United Kingdom
United Kingdom
HOWARD, ZACHARY C
2020-06-1216772216PLASMID SYSTEMAUTOLUS LIMITEDPatented Case2024-04-2311965173US20230242937A1
Martin Pulé
Paulo Fernandes
Hanna Kymalainen
Ekaterini Kotsopoulou
United Kingdom
United Kingdom
United Kingdom
United Kingdom
JOHANSEN, PETER N.
2020-05-2116766128POLYPEPTIDEAUTOLUS LIMITEDPatented Case2023-05-1611648274US20200360432A1
Martin Pulé
Matteo Righi
Simon Thomas
Shimobi Onuoha
Shaun Cordoba
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
BUTTICE, AUDREY L
2020-04-2416759222CAR T-CELLS COMPRISING TRANSCRIPTIONAL CIRCUITSAUTOLUS LIMITEDPatented Case2023-12-2611851672US20200308600A1
Martin Pulé
James Sillibourne
Shaun Cordoba
United Kingdom
United Kingdom
United Kingdom
KINSEY WHITE, NICOLE ERIN
2020-04-0816754673CELLAUTOLUS LIMITEDPatented Case2023-05-0911643453US20200255494A1
Martin Pulé
James Sillibourne
Lukas Stanczuk
United Kingdom
United Kingdom
United Kingdom
ZOU, NIANXIANG
2020-03-1216646906CELLAUTOLUS LIMITEDPatented Case2023-07-1811701386US20200297766A1
Martin Pulé
Shaun Cordoba
Simon Thomas
Shimobi Onuoha
Matteo Righi
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
MONSHIPOURI, MARYAM
2019-12-0616620370ANTI TRBC1 ANTIGEN BINDING DOMAINSAUTOLUS LIMITEDPatented Case2022-09-1311440961US20200140549A1
Shaun Cordoba
Simon Thomas
Shimobi Onuoha
Ram Jha
Wen Chean Lim
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
ROARK, JESSICA HOPE
2019-10-1016598652CHIMERIC PROTEINAUTOLUS LIMITEDPatented Case2021-08-3111103532US20200222461A1
Martin Pulé
Ryan Trowbridge
Edward Hodgkin
United Kingdom
United Kingdom
United Kingdom
LONG, SCOTT
2019-09-1716573854CHIMERIC ANTIGEN RECEPTOR (CAR) COMPRISING A CD19-BINDING DOMAINAUTOLUS LIMITEDPatented Case2023-02-1411578126US20200140544A1
Martin Pulé
Leila Mekkaoui
Persis Amrolia
Sara Ghorashian
Anne Kramer
Gordon Cheung
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
SCHULTZ, JAMES
2019-02-1516326131Retroviral And Lentiviral VectorsAUTOLUS LIMITEDPatented Case2023-02-2811591613US20190177746A1
Vijay Peddareddigari
Richard Beswick
John Short
Martin Pulé
Ekaterini Kotsopoulou
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
MARVICH, MARIA
2018-12-2116229684Methods of depleting malignant T-cells.AUTOLUS LIMITEDPatented Case2022-07-1211385233US20200200756A1
Martin Pulé
Paul Maciocia
United Kingdom
United Kingdom
JOHNSON, WAHWAH T
2018-12-1416310121CHIMERIC ANTIGEN RECEPTORAUTOLUS LIMITEDPatented Case2021-11-2311180553US20190177412A1
Shimobi Onuoha
Martin Pulé
Simon Thomas
Shaun Cordoba
Evangelia Kokalaki
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
HARTNETT, BRIAN
2018-12-0616211538A Chimeric Antigen Receptor (CAR) Comprising a CD19-Binding DomainAUTOLUS LIMITEDPatented Case2021-06-1511034750US20190161531A1
Martin Pulé
Shaun Cordoba
Shimobi Onuoha
Simon Thomas
United Kingdom
United Kingdom
United Kingdom
United Kingdom
REDDIG, PETER J
2018-11-1216188185Method of Preparing T Cells with Increased ActivityAUTOLUS LIMITEDPatented Case2024-02-2011903967US20190209612A1
Martin Pulé
Carlotta Petticone
James Faulkner
Ekaterini Kotsopoulou
Emma Chan
Richard Beswick
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
KELLY, ROBERT M
2018-10-1716162747CHIMERIC ANTIGEN RECEPTORAutolus LimitedPatented Case2021-02-1610919951US20190100571A1
Martin Pulé
Kwee Yong
Lydia Lee
Ben Draper
United Kingdom
United Kingdom
United Kingdom
United Kingdom
MONTANARI, DAVID A
2018-08-2716113224CHIMERIC CYTOKINE RECEPTORS AND ENCODING NUCLEIC ACIDSAUTOLUS LIMITEDPatented Case2020-10-1310800855US20190016820A1
Martin Pulé
Shaun Cordoba
Matteo Righi
James Sillibourne
Shimobi Onuoha
Simon Thomas
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
LANDSMAN, ROBERT S
2018-08-0916076760Signalling SystemAUTOLUS LIMITEDPatented Case2022-10-1111466070US20190330299A1
Martin Pulé
Shaun Cordoba
Simon Thomas
Shimobi Onuoha
Maria Stavrou
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
HARTNETT, BRIAN
2018-06-2916024445A CHIMERIC ANTIGEN RECEPTOR (CAR) COMPRISING A CD22-BINDING DOMAINAUTOLUS LIMITEDPatented Case2021-04-2010981970US20180371054A1
Martin Pulé
Shaun Cordoba
Shimobi Onuoha
Simon Thomas
United Kingdom
United Kingdom
United Kingdom
United Kingdom
REDDIG, PETER J
2018-04-2015770110CHIMERIC RECEPTOR WITH LIGAND BINDING EXODOMAIN AND CYTOKINE AND T CELL SIGNALLING ENDODOMAINSAUTOLUS LIMITEDPatented Case2022-02-0811242377US20180312570A1
Martin Pulé
Shaun Cordoba
Matteo Righi
United Kingdom
United Kingdom
United Kingdom
HOWARD, ZACHARY C
2018-02-1915753486CHIMERIC CYTOKINE RECEPTORS AND ENCODING NUCLEIC ACIDSAUTOLUS LIMITEDPatented Case2020-10-1310800854US20180244797A1
Martin Pulé
Shaun Cordoba
Matteo Righi
James Sillibourne
Shimobi Onuoha
Simon Thomas
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
United Kingdom
LANDSMAN, ROBERT S
2017-11-2815577378Chimeric T cellAUTOLUS LIMITEDPatented Case2022-05-3111345734US20190023761A1
Martin Pulé
Shaun Cordoba
Simon Thomas
Khai Kong
United Kingdom
United Kingdom
United Kingdom
United Kingdom
SGAGIAS, MAGDALENE K
2017-10-2415568862NUCLEIC ACID CONSTRUCTAUTOLUS LIMITEDPatented Case2023-03-2811613559US20180099994A1
Martin Pulé
Shaun Cordoba
United Kingdom
United Kingdom
SINGH, ANOOP KUMAR
2017-10-2415568859NUCLEIC ACID CONSTRUCTAUTOLUS LIMITEDPatented Case2022-12-2011530420US20180100163A1
Martin Pulé
Shaun Cordoba
United Kingdom
United Kingdom
HIBBERT, CATHERINE S
2017-09-2215560558CHIMERIC ANTIGEN RECEPTOR COMPRISING A CARTILAGE-OLIGOMERIC MATRIX PROTEIN (COMP) COILED-COIL SPACER DOMAINAUTOLUS LIMITEDPatented Case2021-07-1311058722US20180050065A1
Martin Pulé
Shaun Cordoba
United Kingdom
United Kingdom
REDDIG, PETER J
2017-08-3015554499RETROVIRAL AND LENTIVIRAL VECTORSAUTOLUS LIMITEDPatented Case2021-03-2310954530US20180066280A1
Martin Pulé
Leila Mekkaoui
United Kingdom
United Kingdom
CHESTNUT, BARRY A
2017-06-2315632119CellAUTOLUS LIMITED
UCL BUSINESS PLC
Patented Case2019-01-0810174099US20170340705A1
Martin Pulé
Shaun Cordoba
Shimobi Onuoha
Simon Thomas
United Kingdom
United Kingdom
United Kingdom
United Kingdom
REDDIG, PETER J
2017-06-2315631948CellAUTOLUS LIMITED
UCL BUSINESS PLC
Patented Case2018-10-1610098926US20170340704A1
Martin Pulé
Shaun Cordoba
Shimobi Onuoha
Simon Thomas
United Kingdom
United Kingdom
United Kingdom
United Kingdom
REDDIG, PETER J
2017-05-2515529690A T CELL WHICH CO-EXPRESSES A CD19 CHIMERIC ANTIGEN RECEPTOR AND A CD22 CHIMERIC ANTIGEN RECEPTORAUTOLUS LIMITEDPatented Case2021-08-1711091532US20170369550A1
Martin Pulé
Shaun Cordoba
Shimobi Onuoha
Simon Thomas
United Kingdom
United Kingdom
United Kingdom
United Kingdom
REDDIG, PETER J
2016-09-0215123331CHIMERIC ANTIGEN RECEPTORAUTOLUS LIMITEDPatented Case2021-04-1310975162US20170066838A1
Martin Pulé
John Anderson
Simon Thomas
United Kingdom
United Kingdom
United Kingdom
BURKHART, MICHAEL D

Similar stocks

Stock NameCountryMarket CapPE Ratio
Entera Bio Ltd. (ENTX)$0.485B
REGENXBIO Inc. (RGNX)United States$0.477B-3.30
Tectonic Therapeutic, Inc. (TECX)United States$0.469B-7.68
Prime Medicine, Inc. (PRME)United States$0.557B-3.54
Eikon Therapeutics, Inc. (EIKN)United States$0.446B
Allogene Therapeutics, Inc. (ALLO)United States$0.574B-4.33
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Zura Bio Ltd (ZURA)$0.398B-6.56